Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
1.61B | 1.68B | 1.89B | 2.11B | 2.18B | 1.86B | Gross Profit |
972.56M | 1.00B | 1.09B | 1.20B | 1.32B | 1.16B | EBIT |
19.18M | 22.87M | 22.94M | 67.88M | 193.54M | 184.90M | EBITDA |
84.02M | 88.07M | 95.34M | 135.28M | 253.93M | 246.46M | Net Income Common Stockholders |
-21.50M | -20.33M | -15.29M | 36.61M | 153.75M | 139.19M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
1.69M | 1.95M | 2.54M | 1.79M | 2.39M | 4.24M | Total Assets |
836.79M | 860.81M | 950.88M | 953.94M | 919.54M | 800.14M | Total Debt |
934.61M | 936.11M | 972.65M | 896.01M | 791.05M | 589.36M | Net Debt |
932.92M | 934.16M | 970.12M | 894.22M | 788.66M | 585.12M | Total Liabilities |
1.29B | 1.31B | 1.39B | 1.39B | 1.34B | 1.02B | Stockholders Equity |
-456.84M | -451.59M | -441.93M | -438.18M | -424.95M | -223.98M |
Cash Flow | Free Cash Flow | ||||
-28.02M | 3.64M | -66.08M | -33.32M | 233.11M | 240.59M | Operating Cash Flow |
-9.23M | 27.14M | -9.03M | 36.14M | 300.01M | 279.66M | Investing Cash Flow |
-18.64M | -26.29M | -58.35M | -70.61M | -66.64M | -39.02M | Financing Cash Flow |
27.49M | -1.44M | 68.13M | 33.87M | -235.22M | -237.99M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | $1.60B | 13.12 | 12.40% | 2.27% | 1.81% | 8.09% | |
72 Outperform | $677.71M | 11.65 | 12.09% | 5.85% | -6.32% | -18.35% | |
62 Neutral | $6.90B | 11.05 | 2.80% | 4.27% | 2.67% | -24.92% | |
61 Neutral | $249.62M | 23.71 | 6.73% | ― | -0.77% | -8.89% | |
58 Neutral | $1.19B | 41.49 | 2.28% | 4.26% | -2.68% | -56.16% | |
49 Neutral | $80.35M | ― | -199.78% | ― | -10.41% | 53.85% | |
43 Neutral | $176.30M | ― | 9.10% | ― | -12.36% | 37.69% |
At Sleep Number‘s 2025 Annual Meeting, shareholders voted on several proposals, including the election of directors and amendments to the company’s articles and bylaws. While the election of directors and some proposals, such as the ratification of Deloitte & Touche LLP as the independent registered public accounting firm, were approved, key amendments to declassify the board and eliminate supermajority voting requirements did not pass. The board expressed disappointment at the failure to secure the necessary two-thirds majority for these amendments and plans to resubmit them at the 2026 Annual Meeting, aiming to declassify the board by 2027 contingent on shareholder approval.
The most recent analyst rating on (SNBR) stock is a Hold with a $16.00 price target. To see the full list of analyst forecasts on Sleep Number stock, see the SNBR Stock Forecast page.
On May 23, 2025, Sleep Number Corporation announced that Joel Laing, Vice President, Treasurer, and Chief Accounting Officer, will resign effective June 5, 2025. His departure is amicable and not due to any disagreements with the company. Francis Lee, the Chief Financial Officer, will assume the role of principal accounting officer starting June 6, 2025.
The most recent analyst rating on (SNBR) stock is a Hold with a $16.00 price target. To see the full list of analyst forecasts on Sleep Number stock, see the SNBR Stock Forecast page.
On April 25, 2025, Sleep Number Corporation eliminated the role of Executive Vice President and Chief Innovation Officer, previously held by Annie Bloomquist, as part of a broader organizational redesign. Bloomquist will serve in an advisory role until May 31, 2025, to aid in the transition. The company announced changes to its Executive Leadership Team to enhance efficiency and accountability, with new roles and responsibilities aimed at strengthening company performance and improving customer engagement. These changes are intended to streamline decision-making and better position the company to respond to industry and macroeconomic shifts.
On April 16, 2025, Sleep Number Corporation announced it will release its fiscal first quarter results for 2025 on April 30, 2025, after market close. The company will host a conference call to discuss these results, providing stakeholders with insights into its financial performance and strategic direction.
On March 5, 2025, Sleep Number Corporation announced the appointment of Linda Findley as President, CEO, and Director, effective April 7, 2025. Following a significant decline in the company’s stock price after reporting its 2024 financial results, an amendment to Findley’s offer letter was made on March 31, 2025, to restructure her equity inducement grant. The amendment aims to mitigate shareholder dilution by using a notional share price based on the average closing price in 2024 and includes additional performance metrics for vesting conditions. The amendment also introduces a cash sign-on bonus, part of which Findley will use to purchase company stock, aligning her interests with those of the shareholders.